Começar
AbbVie Inc.AbbVie Inc.AbbVie Inc.

AbbVie Inc.

Sem negociações
Veja nos super gráficos
Visão geral Finanças Notícias Ideias Discussões Sinais técnicos Previsão Sazonais Opções
Títulos

ABBV títulos

Abaixo está a lista de títulos corporativos AbbVie Inc.. Os investidores geralmente optam pelos títulos de uma empresa por sua maior estabilidade em épocas de volatilidade do mercado. Estude preços, rendimentos e outras estatísticas e encontre um investimento confiável.
Símbolo
YTM %
Volume
Preço %
Cupom %
Data de vencimento
Montante em circulação
Valor de face
Valor mín. de denominação
Emissor
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
7,59%150 K77,52%4,63%2042-10-0167,49 M USD1.000,00 USD2.000,00 USDActavis, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
7,40%15 K79,63%4,85%2044-06-1565,23 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7,28%10 K79,20%4,75%2045-03-1553,51 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AA5QDALLERGAN FNDG 15/25
7,15%099,26%3,80%2025-03-15130,22 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
6,75%72 K86,70%4,55%2035-03-15107,65 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
6,15%2,04 M81,32%4,25%2049-11-215,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
6,06%084,97%4,45%2046-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5,95%088,48%4,70%2045-05-142,7 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,93%70 K89,55%4,88%2048-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,91%5,58 M85,27%4,05%2039-11-214 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5,91%58 K86,91%4,40%2042-11-062,6 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,90%2,3 M88,93%4,63%2042-10-01389,22 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,82%1,03 M96,20%5,50%2064-03-151,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,81%2,11 M91,21%4,85%2044-06-151,01 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,76%6,2 M96,12%5,40%2054-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,68%157 K91,21%4,75%2045-03-15827,09 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,59%10 K97,82%5,35%2044-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5,56%091,23%4,30%2036-05-141 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5,50%390 K93,81%4,55%2035-03-151,68 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5,48%093,50%4,50%2035-05-142,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
5,25%7,26 M98,73%5,05%2034-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
5,19%1,1 M99,69%3,80%2025-03-152,89 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,10%20 K92,50%3,20%2029-11-2162,52 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
5,02%12,84 M92,83%3,20%2029-11-215,44 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,98%8,36 M99,85%4,95%2031-03-152 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4,96%099,48%3,60%2025-05-143,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4,87%5,87 M99,75%4,80%2029-03-152,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4,77%6,43 M98,28%4,25%2028-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4,67%7,79 M96,98%2,95%2026-11-213,99 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,66%098,09%3,20%2026-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4,60%1,96 M100,41%4,80%2027-03-152,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
4,11%095,03%2,63%2028-11-1572,11 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
3,86%096,53%2,95%2026-11-219,24 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XXS162262122ALLERGAN FNDG 17/29
3,80%093,63%2,13%2029-06-0136,46 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
4ABGABBVIE 19/31
3,02%089,86%1,25%2031-11-18650 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
3,01%0102,15%3,80%2025-03-151,27 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
2,90%0121,31%4,25%2049-11-214,95 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
2,88%0126,76%4,75%2045-03-155 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS152090781ABBVIE 16/28
2,84%097,49%2,13%2028-11-17750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,83%0128,71%4,85%2044-06-15100 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS212591483ABBVIE 20/28
2,76%099,52%2,63%2028-11-15427,79 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2,76%097,49%2,13%2029-06-01506,09 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2,64%094,91%0,75%2027-11-18750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,35%0123,74%4,55%2035-03-151 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4,40%2042-11-061,1 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3,80%2025-03-15—1.000,00 USD2.000,00 USDAbbVie, Inc.